FDA finds Benicar benefits outweigh risks

FDA completed a safety review of Benicar olmesartan from Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) and said the benefits of the hypertension drug continue to outweigh its risks. The agency bega...